Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Clinical trial NCT00698243 · COMPLETED

Trial details

NCT number: NCT00698243
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Any Solid Tumor or Lymphoma

Start date: 2008-06-01
Primary completion: 2013-02-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.